STEADI-Rx社区药房跌倒预防干预的效果:随机对照试验
该随机对照试验在65家社区药房纳入65岁以上、使用四种以上慢性药物或一种以上增加跌倒风险药物的老年人,评估药房主导的STEADI-Rx跌倒预防干预。干预组73%完成筛查,筛查阳性者72%接受药物审查,但干预组与对照组在跌倒风险和药物负担指数变化上均无差异。
要点
- STEADI-Rx社区药房干预可行,但未降低跌倒风险或减少高风险药物使用。
- 干预组73%完成跌倒风险筛查,筛查阳性者中72%接受药物审查。
- 仅27%筛查阳性者接受药物审查后至少有1条药物相关建议传达给医疗提供者。
核心结论
- STEADI-Rx在社区药房环境中成功实施,但干预组与对照组在跌倒风险和增加跌倒风险药物使用方面无差异。
研究设计与样本
- 随机对照试验,纳入北卡罗来纳州65家社区药房,共10,565名65岁以上、使用四种以上慢性药物或一种以上增加跌倒风险药物的成年人。
- 有连续Medicare Part D/NC Medicaid覆盖的参与者(n=3,212)用于药物负担指数(DBI)和保险索赔记录分析。
主要发现
- 干预组4,719人中73%(3,437人)完成跌倒风险筛查。
- 筛查阳性1,901人中72%(1,373人)接受药物审查,27%(521人)至少有一条药物相关建议传达给医疗提供者。
- 共提出716条具体药物建议。
- DBI评分在干预组和对照组从干预前到干预后均下降,但组间变化量无差异(P=.66)。
- 跌倒风险在干预前后无变化,组间也无差异(P=.58)。
临床怎么用
- 社区药房可实施STEADI-Rx跌倒风险筛查和药物审查流程,但该干预未显示降低跌倒风险或减少高风险药物使用。
- 药物审查后向医疗提供者传达建议的比例较低(27%),提示需优化干预实施策略。
局限性
- 跌倒风险分析仅基于有连续Medicare Part D/NC Medicaid覆盖的参与者(n=3,212),可能存在选择偏倚。
- 干预组仅73%完成筛查,筛查阳性者中72%接受药物审查,实施覆盖不完全。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To evaluate the effects of a community pharmacy-based fall prevention intervention (STEADI-Rx) on the risk of falling and use of medications associated with an increased risk of falling. DESIGN: Randomized controlled trial. SETTING: A total of 65 community pharmacies in North Carolina (NC). PARTICIPANTS: Adults (age ≥65 years) using either four or more chronic medications or one or more medications associated with an increased risk of falling (n = 10,565). INTERVENTION: Pharmacy staff screened patients for fall risk using questions from the Stopping Elderly Accidents, Deaths, and Injuries (STEADI) algorithm. Patients who screened positive were eligible to receive a pharmacist-conducted medication review, with recommendations sent to patients' healthcare providers following the review. MEASUREMENTS: At intervention pharmacies, pharmacy staff used standardized forms to record participant responses to screening questions and information concerning the medication reviews. For participants with continuous Medicare Part D/NC Medicaid coverage (n = 3,212), the Drug Burden Index (DBI) was used to assess exposure to high-risk medications, and insurance claims records for emergency department visits and hospitalizations were used to assess falls. RESULTS: Among intervention group participants (n = 4,719), 73% (n = 3,437) were screened for fall risk. Among those who screened positive (n = 1,901), 72% (n = 1,373) received a medication review; and 27% (n = 521) had at least one medication-related recommendation communicated to their healthcare provider(s) following the review. A total of 716 specific medication recommendations were made. DBI scores decreased from the pre- to postintervention period in both the control and the intervention group. However, the amount of change over time did not differ between these two groups (P = .66). Risk of falling did not change between the pre- to postintervention period or differ between groups (P = .58). CONCLUSION: We successfully implemented STEADI-Rx in the community pharmacy setting. However, we found no differences in fall risk or the use of medications associated with increased risk of falling between the intervention and control groups. J Am Geriatr Soc 68:1778-1786, 2020.
引用
- Blalock SJ, Ferreri SP, Renfro CP, et al. Impact of STEADI-Rx: A Community Pharmacy-Based Fall Prevention Intervention. J Am Geriatr Soc. 2020. PMID: 32315461. doi:10.1111/jgs.16459
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。